Researchers on the »Imaging of Large Tissues« project are developing a workflow to combine the various microscopy imaging methods and analytical, mass spectroscopy methods.
An interdisciplinary consortium of researchers in North Rhine-Westphalia is dedicated to improving the quality of life of patients with neuromuscular diseases by developing new precision diagnostic and treatment methods. Their goal is to find suitable therapies for patients and bring these directly to their bedsides.
The objective of FMC is to develop a mobile measuring instrument which can be used to identify bacteria at meat-processing plants. The hand-held measuring instrument uses a method based on plasma gas chromatography-ion mobility spectrometry (Plasma-GC-IMS).
Researchers aim to develop post-ionisation methods using dual laser-based MSI instrumentation (MALDI-2) in the project »Imaging Tissue Metabolism with Enhanced Sensitivity of Dual Laser Mass Spectrometry«.
In a research project funded by the state government of North Rhine-Westphalia and the European Union, researchers are developing GRK5 inhibitor-based drugs for the treatment of heart failure. The enzyme GRK5 plays a key role in the deterioration of heart function. The new active substances are also designed to take gender- and age-specific aspects of the disease into account.
The special research programme ‘Local Control of Thyroid Hormone Action – LOCOTACT’, led by the University Hospital Essen, is investigating the local control of the effects of thyroid hormones.